2 of the listed companies, Orion Pharma & Orion Infusion Limited discloses its financial reports for the first quarter, (July-September 23).
Orion Pharma: The company’s earnings per share Consolidated (EPS) of Tk 0.76 paisa in Q1 of the current financial year (July-September 23). Consolidated EPS Tk 0.72 paisa during the same period last year. Consolidated NAV per share was of Tk. 89.65 (including surplus) as of September 30, 2023.
Orion Infusion: The company’s earnings per share (EPS) of Tk 0.66 paisa in Q1 of the current financial year (July-September 23). EPS Tk 0.63 paisa during the same period last year. NAV per share was of Tk. 14.94 as of September 30, 2023.
Share this
